153 related articles for article (PubMed ID: 23155232)
1. Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma.
Narayanan BA; Doudican NA; Park J; Xu D; Narayanan NK; Dasgupta R; Mazumder A
Anticancer Res; 2012 Nov; 32(11):4697-707. PubMed ID: 23155232
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt/beta-catenin pathway in multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG
Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106
[TBL] [Abstract][Full Text] [Related]
3. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma.
Savvidou I; Khong T; Cuddihy A; McLean C; Horrigan S; Spencer A
Mol Cancer Ther; 2017 Sep; 16(9):1765-1778. PubMed ID: 28500235
[TBL] [Abstract][Full Text] [Related]
5. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
Giuliani N; Morandi F; Tagliaferri S; Lazzaretti M; Donofrio G; Bonomini S; Sala R; Mangoni M; Rizzoli V
Cancer Res; 2007 Aug; 67(16):7665-74. PubMed ID: 17702698
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma.
Dun X; Jiang H; Zou J; Shi J; Zhou L; Zhu R; Hou J
Mol Cancer; 2010 Sep; 9():247. PubMed ID: 20846389
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
Qiang YW; Chen Y; Brown N; Hu B; Epstein J; Barlogie B; Shaughnessy JD
Br J Haematol; 2010 Mar; 148(5):726-38. PubMed ID: 19961481
[TBL] [Abstract][Full Text] [Related]
9. The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.
Sogutlu F; Kayabasi C; Ozmen Yelken B; Asik A; Gasimli R; Dogan F; Yilmaz Süslüer S; Biray Avcı C; Gunduz C
J Cell Biochem; 2019 Jan; 120(1):380-395. PubMed ID: 30145828
[TBL] [Abstract][Full Text] [Related]
10. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesis.
Henderson LJ; Sharma A; Monaco MC; Major EO; Al-Harthi L
J Neurosci; 2012 Nov; 32(46):16306-13. PubMed ID: 23152614
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway.
Jin Y; Xu L; Wu X; Feng J; Shu M; Gu H; Gao G; Zhang J; Dong B; Chen X
Oncol Res; 2019 Jun; 27(6):729-737. PubMed ID: 30837032
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.
Olkku A; Mahonen A
Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874
[TBL] [Abstract][Full Text] [Related]
15. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
[TBL] [Abstract][Full Text] [Related]
16. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
Liang Y; Li X; He X; Qiu X; Jin XL; Zhao XY; Xu RZ
Eur J Haematol; 2016 Oct; 97(4):371-8. PubMed ID: 26821882
[TBL] [Abstract][Full Text] [Related]
17. Smenospongidine suppresses the proliferation of multiple myeloma cells by promoting CCAAT/enhancer-binding protein homologous protein-mediated β-catenin degradation.
Park S; Hwang IH; Kim J; Chung YH; Song GY; Na M; Oh S
Arch Pharm Res; 2017 May; 40(5):592-600. PubMed ID: 28275987
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Schmeel FC; Schmeel LC; Kim Y; Schmidt-Wolf IG
Hematol Oncol; 2014 Dec; 32(4):197-204. PubMed ID: 24470348
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation.
Choi PJ; O Y; Her JH; Yun E; Song GY; Oh S
Leuk Res; 2017 Sep; 60():103-108. PubMed ID: 28772205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
